JRebel / XRebel Renewal

Closed Solicitation Posted

Solicitation number
FDA-SOL-75F40124Q00283
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring, Maryland 20993, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration (FDA) is seeking to renew 22 JRebel and 15 XRebel software licenses to improve software development productivity and identify performance issues in Java applications. The solicitation is a full and open competition, and the award will be made on a lowest price technically acceptable basis. The period of performance is one year from the date of delivery, with four one-year option periods. Quotes are due by June 17, 2024, and the government intends to award a firm-fixed-price purchase order.

This solicitation is not set aside for any specific business category. The current incumbent or contractor is not named. The total value of the contract is not specified, but the procurement is for 22 JRebel and 15 XRebel software licenses. The place of performance is the FDA facility in Silver Spring, Maryland.

Notice text

JRebel / XRebel Software License 

Files

File Type Posted
FDA-SOL-75F40124Q00283.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Contractor-Hosted Fully Integrated Records Facility (FIRF) IDIQ Silver Spring, Maryland 20993, United States · NAICS 541611 FDA Office of Acquisition and Grant Services Service-Disabled Veteran-Owned Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors